2015
DOI: 10.19104/jstb.2015.104
|View full text |Cite
|
Sign up to set email alerts
|

Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering

Abstract: Myocardial infarction (MI) is the leading cause of death worldwide. Recent advances in stem cell research hold great potential for heart tissue regeneration through stem cell-based therapy. While multiple cell types have been transplanted into MI heart in preclinical studies or clinical trials, reduction of scar tissue and restoration of cardiac function have been modest. Several challenges hamper the development and application of stem cell-based therapy for heart regeneration. Application of cardiac progenit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 141 publications
(139 reference statements)
0
15
0
Order By: Relevance
“…Persistence by cell fusion in neonatal injections is unlikely since cCICs often appear in large clusters (ranging from 100 to 500 μm), and numerous simultaneous cell fusion events all occurring at same location would be unprecedented. Cell death due to inflammation, apoptosis, or necrosis is a major cause for postinjection cell loss, but scant evidence of these processes in donated cCIC (Figure S5) is consistent with their prolonged persistence in the postnatal heart.…”
Section: Discussionmentioning
confidence: 85%
“…Persistence by cell fusion in neonatal injections is unlikely since cCICs often appear in large clusters (ranging from 100 to 500 μm), and numerous simultaneous cell fusion events all occurring at same location would be unprecedented. Cell death due to inflammation, apoptosis, or necrosis is a major cause for postinjection cell loss, but scant evidence of these processes in donated cCIC (Figure S5) is consistent with their prolonged persistence in the postnatal heart.…”
Section: Discussionmentioning
confidence: 85%
“…In contrast, during injection into dense tissue, such as intramuscular injections, the host tissue may provide mechanical support and promote cell survival. However, injection into dense tissue requires higher injection pressures and can still result in cell leakage at the transplantation site [17]. Additionally, cells may be confronted with several other survival challenges during the acute post-injection stage that are not inherently mechanical in nature, including hypoxia, low nutrient transport, and the immune and inflammatory response [18-20].…”
Section: Mechanical Challenges To Successful Stem Cell Transplantationmentioning
confidence: 99%
“…Molecules (with repair and/or regeneration capacities of the damaged tissue) are encapsulated in the hydrogel and released locally over time (the hydrazone bond is then broken and occurs the molecules release from nanoparticles). In several studies it was reported that polymer matrices can be used to sustain the release of encapsulated molecules for up to 100 days and the release profi le initially showed a quick release followed by a slower release rate [6][7][8][9][10]. …”
Section: Introductionmentioning
confidence: 99%